Compare Lucid Group Inc (LCID) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lucid Group Inc vs Novartis AG — how do they compare? Lucid Group Inc trades at $6.66 (market cap $2.60B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is far larger — about 114.7× Lucid Group Inc's market cap, and Novartis AG pays a 3.02% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.
| LCID | NVS | |
|---|---|---|
Market Cap | $2.60B | $298.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.77 | $168.62 |
52-Week Low | $4.62 | $119.31 |
Enterprise Value | $5.50B | $339.50B |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
